Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 71

1.

Heterogeneous cancer-associated fibroblast population potentiates neuroendocrine differentiation and castrate resistance in a CD105-dependent manner.

Kato M, Placencio-Hickok VR, Madhav A, Haldar S, Tripathi M, Billet S, Mishra R, Smith B, Rohena-Rivera K, Agarwal P, Duong F, Angara B, Hickok D, Liu Z, Bhowmick NA.

Oncogene. 2018 Sep 3. doi: 10.1038/s41388-018-0461-3. [Epub ahead of print]

PMID:
30177832
2.

Stromal epigenetic alterations drive metabolic and neuroendocrine prostate cancer reprogramming.

Mishra R, Haldar S, Placencio V, Madhav A, Rohena-Rivera K, Agarwal P, Duong F, Angara B, Tripathi M, Liu Z, Gottlieb RA, Wagner S, Posadas EM, Bhowmick NA.

J Clin Invest. 2018 Oct 1;128(10):4472-4484. doi: 10.1172/JCI99397. Epub 2018 Jul 26.

3.

Notch inhibitor screening reveals an unexpected HES1 heterodimer.

Rohena-Rivera K, Bhowmick NA.

J Biol Chem. 2018 May 25;293(21):8295-8296. doi: 10.1074/jbc.H118.002880.

4.

Antagonizing CD105 enhances radiation sensitivity in prostate cancer.

Madhav A, Andres A, Duong F, Mishra R, Haldar S, Liu Z, Angara B, Gottlieb R, Zumsteg ZS, Bhowmick NA.

Oncogene. 2018 Aug;37(32):4385-4397. doi: 10.1038/s41388-018-0278-0. Epub 2018 May 2.

5.

Regulation of inside-out β1-integrin activation by CDCP1.

Pollan SG, Huang F, Sperger JM, Lang JM, Morrissey C, Cress AE, Chu CY, Bhowmick NA, You S, Freeman MR, Spassov DS, Moasser MM, Carter WG, Satapathy SR, Shah K, Knudsen BS.

Oncogene. 2018 May;37(21):2817-2836. doi: 10.1038/s41388-018-0142-2. Epub 2018 Mar 7.

PMID:
29511352
6.

Reduction of Circulating Cancer Cells and Metastases in Breast-Cancer Models by a Potent EphA2-Agonistic Peptide-Drug Conjugate.

Salem AF, Wang S, Billet S, Chen JF, Udompholkul P, Gambini L, Baggio C, Tseng HR, Posadas EM, Bhowmick NA, Pellecchia M.

J Med Chem. 2018 Mar 8;61(5):2052-2061. doi: 10.1021/acs.jmedchem.7b01837. Epub 2018 Feb 27.

PMID:
29470068
7.

Porphyromonas gingivalis-Derived Lipopolysaccharide Combines Hypoxia to Induce Caspase-1 Activation in Periodontitis.

Cheng R, Liu W, Zhang R, Feng Y, Bhowmick NA, Hu T.

Front Cell Infect Microbiol. 2017 Nov 14;7:474. doi: 10.3389/fcimb.2017.00474. eCollection 2017.

8.

Modulation of cabozantinib efficacy by the prostate tumor microenvironment.

Tripathi M, Nandana S, Billet S, Cavassani KA, Mishra R, Chung LWK, Posadas EM, Bhowmick NA.

Oncotarget. 2017 Sep 23;8(50):87891-87902. doi: 10.18632/oncotarget.21248. eCollection 2017 Oct 20.

9.

S-adenosylmethionine and methylthioadenosine inhibit cancer metastasis by targeting microRNA 34a/b-methionine adenosyltransferase 2A/2B axis.

Tomasi ML, Cossu C, Spissu Y, Floris A, Ryoo M, Iglesias-Ara A, Wang Q, Pandol SJ, Bhowmick NA, Seki E, Posadas EM, Lu SC.

Oncotarget. 2017 Aug 12;8(45):78851-78869. doi: 10.18632/oncotarget.20234. eCollection 2017 Oct 3.

10.

MicroRNA applications for prostate, ovarian and breast cancer in the era of precision medicine.

Smith B, Agarwal P, Bhowmick NA.

Endocr Relat Cancer. 2017 May;24(5):R157-R172. doi: 10.1530/ERC-16-0525. Epub 2017 Mar 13. Review.

11.

MYC Mediates Large Oncosome-Induced Fibroblast Reprogramming in Prostate Cancer.

Minciacchi VR, Spinelli C, Reis-Sobreiro M, Cavallini L, You S, Zandian M, Li X, Mishra R, Chiarugi P, Adam RM, Posadas EM, Viglietto G, Freeman MR, Cocucci E, Bhowmick NA, Di Vizio D.

Cancer Res. 2017 May 1;77(9):2306-2317. doi: 10.1158/0008-5472.CAN-16-2942. Epub 2017 Feb 15. Erratum in: Cancer Res. 2017 Jul 15;77(14 ):3961.

12.

Bone Metastasis of Prostate Cancer Can Be Therapeutically Targeted at the TBX2-WNT Signaling Axis.

Nandana S, Tripathi M, Duan P, Chu CY, Mishra R, Liu C, Jin R, Yamashita H, Zayzafoon M, Bhowmick NA, Zhau HE, Matusik RJ, Chung LW.

Cancer Res. 2017 Mar 15;77(6):1331-1344. doi: 10.1158/0008-5472.CAN-16-0497. Epub 2017 Jan 20.

13.

Histone deacetylase inhibitors mediate DNA damage repair in ameliorating hemorrhagic cystitis.

Haldar S, Dru C, Mishra R, Tripathi M, Duong F, Angara B, Fernandez A, Arditi M, Bhowmick NA.

Sci Rep. 2016 Dec 20;6:39257. doi: 10.1038/srep39257.

14.

Role of EMT in Metastasis and Therapy Resistance.

Smith BN, Bhowmick NA.

J Clin Med. 2016 Jan 27;5(2). pii: E17. doi: 10.3390/jcm5020017. Review.

15.

Cells Comprising the Prostate Cancer Microenvironment Lack Recurrent Clonal Somatic Genomic Aberrations.

Bianchi-Frias D, Basom R, Delrow JJ, Coleman IM, Dakhova O, Qu X, Fang M, Franco OE, Ericson NG, Bielas JH, Hayward SW, True L, Morrissey C, Brown L, Bhowmick NA, Rowley D, Ittmann M, Nelson PS.

Mol Cancer Res. 2016 Apr;14(4):374-84. doi: 10.1158/1541-7786.MCR-15-0330. Epub 2016 Jan 11.

16.

Be resistant to apoptosis: a host factor from gingival fibroblasts.

Cheng R, Hu T, Bhowmick NA.

Cell Death Dis. 2015 Dec 3;6:e2009. doi: 10.1038/cddis.2015.350. No abstract available.

17.

Myeloid-specific TGF-β signaling in bone promotes basic-FGF and breast cancer bone metastasis.

Meng X, Vander Ark A, Lee P, Hostetter G, Bhowmick NA, Matrisian LM, Williams BO, Miranti CK, Li X.

Oncogene. 2016 May 5;35(18):2370-8. doi: 10.1038/onc.2015.297. Epub 2015 Aug 17.

PMID:
26279296
18.

A Review: Phytochemicals Targeting JAK/STAT Signaling and IDO Expression in Cancer.

Arumuggam N, Bhowmick NA, Rupasinghe HP.

Phytother Res. 2015 Jun;29(6):805-17. doi: 10.1002/ptr.5327. Epub 2015 Mar 18. Review.

PMID:
25787773
19.

Inflammation and pyroptosis mediate muscle expansion in an interleukin-1β (IL-1β)-dependent manner.

Haldar S, Dru C, Choudhury D, Mishra R, Fernandez A, Biondi S, Liu Z, Shimada K, Arditi M, Bhowmick NA.

J Biol Chem. 2015 Mar 6;290(10):6574-83. doi: 10.1074/jbc.M114.617886. Epub 2015 Jan 16.

20.

Gingival fibroblasts resist apoptosis in response to oxidative stress in a model of periodontal diseases.

Cheng R, Choudhury D, Liu C, Billet S, Hu T, Bhowmick NA.

Cell Death Discov. 2015 Nov 9;1:15046. doi: 10.1038/cddiscovery.2015.46. eCollection 2015.

Supplemental Content

Loading ...
Support Center